Roche CFO Says Co. Commited to Genentech (DNA) Deal -Reuters

January 12, 2009 1:00 PM EST

Reuters is reporting that Roche's (OTC: RHHBY) CFO, Erich Hunziker, has made comments saying that Roche is committed to the Genentech (NYSE: DNA) transaction.

Genentech, Inc. engages in the discovery, development, manufacture, and commercialization of pharmaceutical products in the United States.


Related Categories

Corporate News
Mergers and Acquisitions
Trader Talk

Stocks Mentioned

DNA 94.81

+0.00 +0.00%
Volume: 6,877,884
Track DNA

RHHBY 40.44

+0.00 +0.00%
Volume: 374,718
Track RHHBY


Add Your Comment